• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国轻度认知障碍患者认知和功能进展的分类、预测和一致性:潜在类别分析。

Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis.

机构信息

F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Analysis Group, Los Angeles, CA, USA.

出版信息

J Alzheimers Dis. 2021;82(4):1667-1682. doi: 10.3233/JAD-210305.

DOI:10.3233/JAD-210305
PMID:34219723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8461667/
Abstract

BACKGROUND

Progression trajectories of patients with mild cognitive impairment (MCI) are currently not well understood.

OBJECTIVE

To classify patients with incident MCI into different latent classes of progression and identify predictors of progression class.

METHODS

Participants with incident MCI were identified from the US National Alzheimer's Coordinating Center Uniform Data Set (09/2005-02/2019). Clinical Dementia Rating (CDR®) Dementia Staging Instrument-Sum of Boxes (CDR-SB), Functional Activities Questionnaire (FAQ), and Mini-Mental State Examination (MMSE) score longitudinal trajectories from MCI diagnosis were fitted using growth mixture models. Predictors of progression class were identified using multivariate multinomial logistic regression models; odds ratios (ORs) and 95% confidence intervals (CIs) were reported.

RESULTS

In total, 21%, 22%, and 57% of participants (N = 830) experienced fast, slow, and no progression on CDR-SB, respectively; for FAQ, these figures were 14%, 23%, and 64%, respectively. CDR-SB and FAQ class membership was concordant for most participants (77%). Older age (≥86 versus≤70 years, OR [95% CI] = 5.26 [1.78-15.54]), one copy of APOE ɛ4 (1.94 [1.08-3.47]), higher baseline CDR-SB (2.46 [1.56-3.88]), lower baseline MMSE (0.85 [0.75-0.97]), and higher baseline FAQ (1.13 [1.02-1.26]) scores were significant predictors of fast progression versus no progression based on CDR-SB (all p < 0.05). Predictors of FAQ class membership were largely similar.

CONCLUSION

Approximately a third of participants experienced progression based on CDR-SB or FAQ during the  4-year follow-up period. CDR-SB and FAQ class assignment were concordant for the vast majority of participants. Identified predictors may help the selection of patients at higher risk of progression in future trials.

摘要

背景

目前,轻度认知障碍(MCI)患者的进展轨迹尚不清楚。

目的

将发生 MCI 的患者分为不同的进展潜在类别,并确定进展类别的预测因素。

方法

参与者为美国国家阿尔茨海默病协调中心统一数据集(2005 年 9 月至 2019 年 2 月)中的新发病例 MCI 患者。使用增长混合模型拟合从 MCI 诊断开始的临床痴呆评定量表(CDR®)痴呆分期工具-总框数(CDR-SB)、功能活动问卷(FAQ)和简易精神状态检查(MMSE)评分的纵向轨迹。使用多元多项逻辑回归模型确定进展类别的预测因素;报告优势比(OR)和 95%置信区间(CI)。

结果

共有 21%、22%和 57%的参与者(N=830)在 CDR-SB 上分别经历了快速、缓慢和无进展;对于 FAQ,这些数字分别为 14%、23%和 64%。CDR-SB 和 FAQ 类别的成员资格对大多数参与者是一致的(77%)。年龄较大(≥86 岁与≤70 岁相比,OR[95%CI]为 5.26[1.78-15.54])、携带 APOE ε4 基因 1 个拷贝(1.94[1.08-3.47])、基线 CDR-SB 较高(2.46[1.56-3.88])、基线 MMSE 较低(0.85[0.75-0.97])和基线 FAQ 较高(1.13[1.02-1.26])是基于 CDR-SB 预测快速进展与无进展的显著预测因素(均 p<0.05)。FAQ 类别的预测因素基本相似。

结论

大约三分之一的参与者在 4 年的随访期间基于 CDR-SB 或 FAQ 经历了进展。CDR-SB 和 FAQ 类别的分配在绝大多数参与者中是一致的。确定的预测因素可能有助于在未来的试验中选择进展风险较高的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b8/8461667/9e60e5c4e94d/jad-82-jad210305-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b8/8461667/d19cc39280eb/jad-82-jad210305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b8/8461667/e491b35f7bd3/jad-82-jad210305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b8/8461667/9e60e5c4e94d/jad-82-jad210305-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b8/8461667/d19cc39280eb/jad-82-jad210305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b8/8461667/e491b35f7bd3/jad-82-jad210305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b8/8461667/9e60e5c4e94d/jad-82-jad210305-g003.jpg

相似文献

1
Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis.美国轻度认知障碍患者认知和功能进展的分类、预测和一致性:潜在类别分析。
J Alzheimers Dis. 2021;82(4):1667-1682. doi: 10.3233/JAD-210305.
2
Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.阿尔茨海默病的认知和功能进展:潜在类别预测模型。
Int J Geriatr Psychiatry. 2018 Aug;33(8):1057-1064. doi: 10.1002/gps.4893. Epub 2018 May 15.
3
Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.内侧颞叶萎缩的视觉评估作为轻度认知障碍向痴呆转化的临床标志物以及预测轻度认知障碍和轻度阿尔茨海默病患者病情进展的研究
Dement Geriatr Cogn Disord. 2017;44(1-2):12-24. doi: 10.1159/000477342. Epub 2017 Jun 15.
4
Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data.淀粉样蛋白阳性早期阿尔茨海默病疾病进展减缓的潜在影响:来自真实世界数据的估计。
J Prev Alzheimers Dis. 2024;11(2):310-319. doi: 10.14283/jpad.2024.27.
5
Psychometric Properties of the Clinical Dementia Rating - Sum of Boxes and Other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population.临床痴呆评定量表-框总和及其它认知和功能结局在前驱期阿尔茨海默病人群中的心理测量特性。
J Prev Alzheimers Dis. 2021;8(2):151-160. doi: 10.14283/jpad.2020.73.
6
Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire.简化阿尔茨海默病监测:一种使用简易精神状态检查和功能活动问卷估算临床痴呆评定量表总分变化的新型机器学习方法。
J Alzheimers Dis. 2024;99(3):953-963. doi: 10.3233/JAD-231426.
7
Metrological properties of neuropsychological tests for measuring cognitive change in individuals with prodromal Alzheimer's disease.在有前驱阿尔茨海默病的个体中测量认知变化的神经心理学测验的计量学特性。
Aging Ment Health. 2022 Oct;26(10):1988-1996. doi: 10.1080/13607863.2021.1966746. Epub 2021 Aug 19.
8
Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.国家阿尔茨海默病协调中心数据库中临床痴呆评定量表方框总分新解释指南的验证
Arch Neurol. 2010 Jun;67(6):746-9. doi: 10.1001/archneurol.2010.115.
9
Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Findings from a Longitudinal Cohort Analysis.淀粉样蛋白阳性早期阿尔茨海默病疾病进展差异率的影响:来自纵向队列分析的结果。
J Prev Alzheimers Dis. 2024;11(2):320-328. doi: 10.14283/jpad.2024.28.
10
Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.帕金森病与阿尔茨海默病中的轻度认知障碍。
Parkinsonism Relat Disord. 2016 Jun;27:54-60. doi: 10.1016/j.parkreldis.2016.04.007. Epub 2016 Apr 9.

引用本文的文献

1
Changes in cognitive functioning and quality of life after relocation to a nursing home: a prospective longitudinal study of Swiss nursing home residents.搬入养老院后认知功能和生活质量的变化:一项针对瑞士养老院居民的前瞻性纵向研究。
Eur J Ageing. 2025 Jul 22;22(1):35. doi: 10.1007/s10433-025-00869-7.
2
Prediction and clustering of Alzheimer's disease by race and sex: a multi-head deep-learning approach to analyze irregular and heterogeneous data.种族和性别对阿尔茨海默病的预测和聚类:一种分析不规则和异质数据的多头深度学习方法。
Sci Rep. 2024 Nov 4;14(1):26668. doi: 10.1038/s41598-024-77829-1.
3
Trajectories and influencing factors of cognitive function and physical disability in Chinese older people.

本文引用的文献

1
Factors associated with slow progression of cognitive impairment following first dementia diagnosis.与首次痴呆诊断后认知障碍进展缓慢相关的因素。
Int J Geriatr Psychiatry. 2021 Feb;36(2):271-285. doi: 10.1002/gps.5420. Epub 2020 Sep 15.
2
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease.脑脊液中的突触生物标志物有助于诊断,与认知相关,并可预测轻度认知障碍和阿尔茨海默病的进展。
Alzheimers Dement (N Y). 2019 Dec 9;5:871-882. doi: 10.1016/j.trci.2019.11.002. eCollection 2019.
3
Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics.
中国老年人认知功能和身体残疾轨迹及其影响因素。
Front Public Health. 2024 Jul 4;12:1380657. doi: 10.3389/fpubh.2024.1380657. eCollection 2024.
4
Prognostic and Predictive Factors in Early Alzheimer's Disease: A Systematic Review.早期阿尔茨海默病的预后和预测因素:一项系统评价
J Alzheimers Dis Rep. 2024 Feb 16;8(1):203-240. doi: 10.3233/ADR-230045. eCollection 2024.
使用影像学、CSF、遗传因素、认知弹性和人口统计学预测短期 MCI 向 AD 的进展。
Sci Rep. 2019 Feb 19;9(1):2235. doi: 10.1038/s41598-019-38793-3.
4
Factors influencing attrition in 35 Alzheimer's Disease Centers across the USA: a longitudinal examination of the National Alzheimer's Coordinating Center's Uniform Data Set.影响美国 35 家阿尔茨海默病中心人员流失的因素:对国家阿尔茨海默病协调中心统一数据集的纵向研究。
Aging Clin Exp Res. 2019 Sep;31(9):1283-1297. doi: 10.1007/s40520-018-1087-6. Epub 2018 Dec 10.
5
Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.国家阿尔茨海默病协调中心的统一数据集第 3 版。
Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):351-358. doi: 10.1097/WAD.0000000000000279.
6
Modeling and prediction of clinical symptom trajectories in Alzheimer's disease using longitudinal data.使用纵向数据对阿尔茨海默病临床症状轨迹进行建模和预测。
PLoS Comput Biol. 2018 Sep 14;14(9):e1006376. doi: 10.1371/journal.pcbi.1006376. eCollection 2018 Sep.
7
Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.阿尔茨海默病的认知和功能进展:潜在类别预测模型。
Int J Geriatr Psychiatry. 2018 Aug;33(8):1057-1064. doi: 10.1002/gps.4893. Epub 2018 May 15.
8
Predictors of Rapid Cognitive Decline in Patients with Mild-to-Moderate Alzheimer Disease: A Prospective Cohort Study with 12-Month Follow-Up Performed in Memory Clinics.轻度至中度阿尔茨海默病患者认知迅速下降的预测因素:在记忆诊所进行的为期 12 个月的前瞻性队列研究。
Dement Geriatr Cogn Disord. 2018;45(1-2):56-65. doi: 10.1159/000487938. Epub 2018 Apr 23.
9
Data-driven identification of endophenotypes of Alzheimer's disease progression: implications for clinical trials and therapeutic interventions.基于数据的阿尔茨海默病进展的内表型识别:对临床试验和治疗干预的影响。
Alzheimers Res Ther. 2018 Jan 15;10(1):4. doi: 10.1186/s13195-017-0332-0.
10
Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.实践指南更新概要:轻度认知障碍:美国神经病学学会指南制定、传播和实施小组委员会的报告。
Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27.